Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Nu Holdings
NU
5
Liberty Latin America-A
LILA
CN Stock MarketDetailed Quotes
300759 Pharmaron Beijing
- 23.14
- +0.06+0.26%
Trading Apr 25 10:34 CST
41.15BMarket Cap22.93P/E (TTM)
23.57High22.91Low112.50KlotVolume23.40Open23.08Pre Close261.58MTurnover0.79%Turnover Ratio22.93P/E (Static)1.78BShares36.4252wk High3.02P/B32.84BFloat Cap17.7052wk Low27.70Limit Up1.42BShs Float108.11Historical High18.46Limit Down2.86%Amplitude3.24Historical Low0.20Dividend TTM23.25Avg Price55.02KlotAsk0.86%Div YieldTTM100Lot Size48.23KlotBid
About Pharmaron Beijing Company
The company is an internationally leading life science research and development service enterprise. Since its establishment in 2004, the company has been committed to its talent training and facility construction, and has built an R&D and production service system throughout the entire process of drug discovery, pre-clinical and clinical development for multi-therapy drug research and development, including small molecules, macromolecules, and cell and gene therapy drugs. The company is a leading full-process integrated pharmaceutical R&D service platform.
Company Profile
Short Name-A康龙化成
Symbol-A300759
Short Name-H康龙化成
Symbol-H03759
Company NamePharmaron Beijing Co., Ltd.
Listing DateJan 28, 2019
Issue Price7.66
Shares Offered65.63M share(s)
FoundedJul 1, 2004
Legal RepresentativeBoliang Lou
General Managerxiaoqiang lou
Secretarychengzong li
Accounting FirmErnst & Young Huaming Certified Public Accountants (Special General Partnership)
Legal CounselBeijing Zhong Lun Law Firm
Employees6767
Phone010-57330087
Office AddressNo. 6 Taihe Road, Beijing Economic and Technological Development Zone, Beijing
Zip Code100176
Registered Address8th Floor, Building 1, No. 6 Taihe Road, Beijing Economic and Technological Development Zone, Beijing
Fax010-57330087
Emailpharmaron@pharmaron.com
Websitehttp://www.pharmaron.cn/
Business License110000410205747
BusinessResearch and development of medicinal compounds, chemicals, biological products, and biotechnology; provision of technical development, technology transfer, technical consulting, technical services, technical training; import and export of goods and technology. (For projects subject to approval according to law, business activities are carried out according to the approved content after approval by the relevant departments.) (Subject to the scope of business approved by the market supervisory and regulatory authority)
Company Executives
- Name
- Position
- Salary
- Boliang Lou
- Chairman, Executive Director, CEOs, Nomination Committee Members, Member of the Remuneration and Assessment Committee, Chairman of the Strategy Committee
- 2.21M
- jiaqing li
- Non-executive Directors, Strategy Committee Member
- --
- xiaoqiang lou
- Executive Director, President, Strategy Committee Member, Member of the Remuneration and Assessment Committee, Chief Operating Officer
- 1.91M
- baifeng hu
- Non-executive Directors, Strategy Committee Member
- --
- bei zheng
- Executive Director, Executive Vice President (Deputy Manager), Nomination Committee Members
- 1.60M
- kunhongxiansheng ceng
- Independent Non-Executive Director, Nomination Committee Members, Member of the Remuneration and Assessment Committee, Audit Committee Member
- 220.00K
- jian yu
- Independent Non-Executive Director, Nomination Committee Members, Member of the Remuneration and Assessment Committee, Chairman of the Audit Committee
- 300.00K
- lihua li
- Independent Non-Executive Director, Audit Committee Member, Chairman of the Remuneration and Assessment Committee, Chairman of the Nomination Committee
- 300.00K
- Gilbert Shing Chung Li
- Board Secretary, Chief Financial Officer (Head of Finance)
- 6.89M
- Kexin Yang
- Chairman of the Supervisory Board, Auditors
- 1.40M
- shu feng
- Auditors
- --
- Hua Yang
- Chief Scientific Officer (Deputy Manager), Core technical personnel
- 1.91M
- lan zhang
- Employee Supervisors
- 764.90K
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs